| Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018 | 949 | 2018 |
| Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry A Antonini, W Poewe, KR Chaudhuri, R Jech, B Pickut, Z Pirtošek, J Szasz, ... Parkinsonism & related disorders 45, 13-20, 2017 | 190 | 2017 |
| Age as an independent factor for the development of neuropathy in diabetic patients S Popescu, B Timar, F Baderca, M Simu, L Diaconu, I Velea, R Timar Clinical interventions in aging 11, 313, 2016 | 87 | 2016 |
| Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis–osteopontin as a potential marker of clinical severity L Szalardy, D Zadori, M Simu, K Bencsik, L Vecsei, P Klivenyi Journal of the neurological sciences 331 (1-2), 38-42, 2013 | 66 | 2013 |
| The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience O Băjenaru, A Ene, BO Popescu, JA Szasz, M Sabău, DF Mureşan, ... Journal of Neural Transmission 123 (4), 407-414, 2016 | 49 | 2016 |
| Montreal Cognitive Assessment (MoCA) for HIV-associated neurocognitive disorders EC Rosca, L Albarqouni, M Simu Neuropsychology review 29 (3), 313-327, 2019 | 48 | 2019 |
| Research Repository EC Rosca, L Albarqouni, M Simu | 48* | |
| Predictors and clinical impact of delayed stent thrombosis after thrombectomy for acute stroke with tandem lesions R Pop, I Zinchenko, V Quenardelle, D Mihoc, M Manisor, JS Richter, ... American Journal of Neuroradiology 40 (3), 533-539, 2019 | 44 | 2019 |
| The usefulness of quantifying intraepidermal nerve fibers density in the diagnostic of diabetic peripheral neuropathy: a cross-sectional study B Timar, S Popescu, R Timar, F Baderca, B Duica, M Vlad, C Levai, ... Diabetology & metabolic syndrome 8 (1), 1-7, 2016 | 41 | 2016 |
| The role of personality dimensions and trait anxiety in increasing the likelihood of suicide ideation in women during the perinatal period I Enătescu, M Craina, A Gluhovschi, C Giurgi-Oncu, L Hogea, ... Journal of Psychosomatic Obstetrics & Gynecology, 1-11, 2020 | 39 | 2020 |
| Application of the ‘5-2-1’screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE J Aldred, M Anca-Herschkovitsch, A Antonini, O Bajenaru, L Bergmann, ... Neurodegenerative Disease Management 10 (5), 309-323, 2020 | 35 | 2020 |
| Risk for major bleeding in patients receiving ticagrelor compared with aspirin after transient ischemic attack or acute ischemic stroke in the SOCRATES study (Acute stroke or … JD Easton, M Aunes, GW Albers, P Amarenco, S Bokelund-Singh, ... Circulation 136 (10), 907-916, 2017 | 35 | 2017 |
| The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis F Gadalean, M Simu, F Parv, R Vorovenci, R Tudor, A Schiller, R Timar, ... PLoS One 12 (10), e0185589, 2017 | 34 | 2017 |
| Affective theory of mind in Parkinson’s disease: the effect of cognitive performance AM Romosan, L Dehelean, RS Romosan, M Andor, AC Bredicean, ... Neuropsychiatric disease and treatment 15, 2521, 2019 | 31 | 2019 |
| HIV-associated neurocognitive disorders: a historical review EC Rosca, O Rosca, M Simu, RD Chirileanu The neurologist 18 (2), 64-67, 2012 | 29 | 2012 |
| Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis L Szalardy, D Zadori, E Tanczos, M Simu, K Bencsik, L Vecsei, P Klivenyi Neuroscience Letters 554, 131-134, 2013 | 28 | 2013 |
| Ticagrelor added to aspirin in acute ischemic stroke or transient ischemic attack in prevention of disabling stroke: a randomized clinical trial P Amarenco, H Denison, SR Evans, A Himmelmann, S James, ... JAMA neurology 78 (2), 177-185, 2021 | 27 | 2021 |
| The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients … N De Stefano, M Filippi, C Confavreux, P Vermersch, M Simu, C Sindic, ... Multiple Sclerosis Journal 15 (2), 238-243, 2009 | 26 | 2009 |
| DUOGLOBE: One‐year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease DG Standaert, J Aldred, M Anca‐Herschkovitsch, P Bourgeois, E Cubo, ... Movement Disorders Clinical Practice, 0 | 25 | |
| Natalizumab changes the peripheral profile of the Th17 panel in MS patients: new mechanisms of action RI Balasa, M Simu, S Voidazan, LI Barcutean, Z Bajko, A Hutanu, I Simu, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 24 | 2017 |
